Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:01:43 EDT Tue 30 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:CRMD from 2023-05-01 to 2024-04-30 - 31 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-19 08:30U:CRMDNews ReleaseCorMedix Inc. Announces CMS Grants TDAPA to DefenCath
2024-04-15 08:30U:CRMDNews ReleaseCorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath(TM) (Taurolidine and Heparin)
2024-04-11 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
2024-04-08 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
2024-03-27 08:30U:CRMDNews ReleaseCorMedix Inc. to Present at the Needham Annual Healthcare Conference
2024-03-12 07:30U:CRMDNews ReleaseCorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2024-03-06 08:30U:CRMDNews ReleaseCorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024
2024-01-30 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Commercial and Reimbursement Updates
2024-01-08 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Commercial and Operational Updates
2023-12-15 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Appointment of Chief Legal Officer
2023-12-04 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Partnership With The Leapfrog Group
2023-11-15 12:58U:CRMDNews ReleaseCorMedix Inc. Announces FDA Approval of DefenCath ‚ ® to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients
2023-11-14 16:05U:CRMDNews ReleaseCorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update
2023-11-02 08:30U:CRMDNews ReleaseCorMedix Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on November 14, 2023
2023-10-11 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference
2023-09-26 08:30U:CRMDNews ReleaseCorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
2023-09-08 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology
2023-09-06 08:30U:CRMDNews ReleaseCorMedix Inc. to Present at the H.C. Wainwright Annual Global Investment Conference
2023-08-30 08:00U:CRMDNews ReleaseCorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath
2023-08-08 07:30U:CRMDNews ReleaseCorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business Update
2023-07-26 08:30U:CRMDNews ReleaseCorMedix Inc. to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 8, 2023
2023-06-28 22:57U:CRMDNews ReleaseCorMedix Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Pre-Funded Warrants
2023-06-28 16:08U:CRMDNews ReleaseCorMedix Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
2023-06-21 08:30U:CRMDNews ReleaseCorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath
2023-06-15 08:30U:CRMDNews ReleaseCormedix Inc. Announces Strategic Initiative With Boston Medical Center to Reduce Health Disparities in Patients at Risk for Bloodstream Infections
2023-05-30 08:30U:CRMDNews ReleaseCormedix Inc. To Present At The Jefferies Healthcare Conference
2023-05-16 07:00U:CRMDNews ReleaseCorMedix Inc. Announces Resubmission of New Drug Application for DefenCath
2023-05-15 16:05U:CRMDNews ReleaseCorMedix Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
2023-05-08 08:30U:CRMDNews ReleaseCorMedix Inc. To Report First Quarter 2023 Financial Results and Provide a Corporate Update on May 15, 2023
2023-05-03 08:30U:CRMDNews ReleaseCorMedix Inc. to Participate in Two Upcoming Investor Conferences
2023-05-01 08:30U:CRMDNews ReleaseCorMedix Inc. Announces Notice of Allowance for U.S. Patent Application Covering Lead Product DefenCath